A Correction to this paper has been published: https://doi.org/10.1038/s41421-021-00267-0
Correction to: Cell Discovery (2020) 6:96
https://doi.org/10.1038/s41421-020-00235-0 Published online 22 December 2020
We apologize for the mistake of the author affiliation information. In the initial published version of this article1, there was an omission in author affiliations. “University of the Chinese Academy of Sciences, Beijing 100049, China” needs to be added to the affiliation of Yuan Sun, Qingxing Wang, Xiaming Jiang and Gengfu Xiao as the author’s second affiliation. The correct information is as follows. This correction does not affect the description of the results or the conclusion of this work. Lei-Ke Zhang1, Yuan Sun1,2, Haolong Zeng3, Qingxing Wang1,2, Xiaming Jiang1,2, Wei-Juan Shang1, Yan Wu1, Shufen Li1, Yu-Lan Zhang1, Zhao-Nian Hao4, Hongbo Chen5, Runming Jin5, Wei Liu6, Hao Li6, Ke Peng1, Gengfu Xiao1,2. 1State Key Laboratory of Virology, Wuhan Institute of Virology, Center for Biosafety Mega-Science, Chinese Academy of Sciences, Wuhan, Hubei 430071, China. 2University of the Chinese Academy of Sciences, Beijing 100049, China. 3Department of Laboratory Medicine, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei 430030, China. 4Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei 430022, China. 5Department of Pediatrics, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei 430022, China. 6Beijing Institute of Microbiology and Epidemiology, State Key Laboratory of Pathogen and Biosecurity, Beijing 100071, China
Reference
Zhang, L. K. et al. Calcium channel blocker amlodipine besylate therapy is associated with reduced case fatality rate of COVID-19 patients with hypertension. Cell Discov. 6, 96 (2020).
Author information
Authors and Affiliations
Corresponding authors
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
About this article
Cite this article
Zhang, LK., Sun, Y., Zeng, H. et al. Author Correction: Calcium channel blocker amlodipine besylate therapy is associated with reduced case fatality rate of COVID-19 patients with hypertension. Cell Discov 7, 29 (2021). https://doi.org/10.1038/s41421-021-00267-0
Published:
DOI: https://doi.org/10.1038/s41421-021-00267-0
